Additionally, Discoidin domain Receptor 2 (DDR2), a tyrosine kinase, is considered as a biomarker, as its mutation promotes tumor growth, particularly in 30% of squamous NSCLC [61]. The gene discussed is DDR2; the disease is neoplasm.